2016
Clinical implications of Paracoccus yeeii bacteremia in a patient with decompensated cirrhosis
Sack J, Peaper DR, Mistry P, Malinis M. Clinical implications of Paracoccus yeeii bacteremia in a patient with decompensated cirrhosis. IDCases 2016, 7: 9-10. PMID: 27920982, PMCID: PMC5133649, DOI: 10.1016/j.idcr.2016.11.008.Peer-Reviewed Case Reports and Technical NotesThird-generation cephalosporinsDecompensated cirrhosisVariceal hemorrhageGeneration cephalosporinsProphylactic antimicrobial treatmentDrug-resistant organismsAdvanced cirrhosisGastrointestinal hemorrhageClinical sepsisNegative patientsRare infectionUncommon organismsInfectious sourceCirrhosisPatientsResistant organismsAntimicrobial treatmentClinical implicationsHemorrhageNegative organismsBacteremiaFirst caseInfectionCephalosporins
2015
Tu1044 Sofosbuvir-Based Interferon-Free Regimens for Hepatitis C Infection in Patients With Compensated and Decompensated Cirrhosis: Interim Analysis of a Prospective Observational Cohort
Do A, Lim J, Liapakis A, Babas G, Caldwell C, Fortune B, Emre S, Kulkarni S, Lempit S, Mistry P, Mulligan D, Rodriguez-Davalos M, Schilsky M, Tichy E, Yoo P, Jakab S. Tu1044 Sofosbuvir-Based Interferon-Free Regimens for Hepatitis C Infection in Patients With Compensated and Decompensated Cirrhosis: Interim Analysis of a Prospective Observational Cohort. Gastroenterology 2015, 148: s-1094-s-1095. DOI: 10.1016/s0016-5085(15)33733-1.Peer-Reviewed Original Research